Features of the content of homocysteine and thyroid hormones in pregnant women with uterine myoma
https://doi.org/10.21518/2079-701X-2020-3-160-163
Abstract
The purpose and objectives of the study is to assess the effect of hyperhomocysteinemia on the first trimester of gestation in women with uterine myoma. Relevance. Biochemical and hormonal changes that occur in the myometrium and the body of a woman as a whole, without preventing the onset of pregnancy, can have a significant effect on the formation of the chorion and the clinical course of the gestational process, provoking complications such as miscarriage. Material and research methods. To achieve this goal, we examined 182 pregnant women, of which the main group was 98 pregnant women with a verified diagnosis of uterine fibroids, which took place before gestation, but did not prevent pregnancy. The comparison group included 84 pregnant women without anamnestic indications of gynecological pathology and signs of fetoplacental insufficiency. Results. We made an attempt to highlight the features of the content of homocysteine and thyroid hormones in pregnant women with uterine myoma and the influence of these indicators on the onset of gestation. Considering the results obtained, we indicate that pregnant women with uterine fibroids and without a tumor had significant differences in individual values. Conclusions. In women with benign tumors of the uterus that are pregnant, the most common conditions in the first trimester are mild anemia and genital tract bleeding. Half of the observed pregnant women with uterine myoma have hyperhomocysteinemia and, in some of them, subclinical hypothyroidism. This must be considered when preparing for the pregnancy of these women.
About the Authors
E. F. KhamidullinaRussian Federation
Elmira F. Khamidullina, Postgraduate Student, Department of Postgraduate Education and Family Medicine
42, L’va Tolstogo St., Ul’yanovsk, 432017
L. Yu. Davidyan
Russian Federation
Liana Y. Davidyan, Doctor of Medical Sciences, Professor, Department of Postgraduate Education and Family Medicine
42, L’va Tolstogo St., Ul’yanovsk, 432017
References
1. Ageeva L.I., Aleksandrova G.A., Zaychenko N.M., Kirillova G.N., Leonov S.A., Mukhina T.V. et al. Healthcare in Russia 2015. Moscow: Rosstat; 2015, 174 p. (In Russ.) Available at: https://psychiatr.ru/download/2555?view=1&name=zdrav15.pdf.
2. Bazhenova L.G., Shramko S.V., Sabantsev M.A., Gulyaeva L.F. Modern view on the pathogenesis of proliferative diseases of the uterus. Rossiyskiy vestnik akushera-ginekologa = Russian Bulletin of Obstetrician-Gynecologist. 2018;(6):31–40. (In Russ.) doi: 10.17116/rosakush20181806131.
3. Baird D.D., Dunson D.B., David B. Why is parity protective for uterine fibroids? Epidemiology. 2003;14(2):247–250. doi: 10.1097/01.EDE.0000054360.61254.27.
4. Shchukina N.A., Sheina E.N., Barinova I.V. Clinical and morphological features of uterine myoma in young women. Rossiyskiy vestnik akushera-ginekologa = Russian Bulletin of Obstetrician-Gynecologist. 2014,14(5):28–31. (In Russ.) Available at: https://www.mediasphera.ru/issues/rossijskij-vestnikakusheraginekologa/2014/5/031726-6122201456.
5. Lipatov I.S., Tuzikov Yu.V., Kutuzova O.A., Prikhod’ko A.V., Frolova N.A., Ryabova S.A. Clinical and pathogenetic variants of maladaptation to pregnancy at early stages of gestation. Akusherstvo, ginekologiya i reproduktsiya = Obstetrics, Gynecology and Reproduction. 2017;11(1):5–13. doi: 10.17749/23137347.2017.11.1.005-013.
6. Gerilovich L.A., Salmina A.B., Egorova A.T., Zhirova N.V. The role of hyperhomocysteinemia in reproductive losses and the methods of its correction. Akusherstvo i ginekologiya = Obstetrics and Gynecology. 2013;(4):84– 88. (In Russ.) Available at: https://aig-journal.ru/articles/Rolgipergomocisteinemiiv-realizacii-reproduktivnyh-poter-i-metody-ee-korrekcii.html.
7. Kostyuchenko G.I. Hyperhomocysteinemia: clinical significance, age cheracteristics, diagnosis and correction. Klinicheskaya gerontologiya = Clinical Gerontology. 2007;(4):32–40. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=11018354.
8. den Heijer M., Miranda B.A.J. Keijzer. Hyperhomocysteinemia as a risk factor for venous thrombosis. Clin Chem Lab Med. 2001;39(8):710–713. doi: 10.1515/CCLM.2001.117.
9. den Heijer M., Miranda B.A.J. Keijzer. Hyperhomocysteinemia as a risk factor for venous thrombosis. Clin Chem Lab Med. 2001;39(8):710–713. doi: 10.1515/CCLM.2001.117.
10. Ayav A., Alberto J.M., Barbe F., Brunaud L., Gerard P., Merten M., Gueant J.L. Defective remethylation of homocysteine is related to decreased synthesis of coenzymes B2 in thyroidectomized rats. Amino Acids. 2005;28:37–43. doi: 10.1007/s00726-004-0151-z.
Review
For citations:
Khamidullina EF, Davidyan LY. Features of the content of homocysteine and thyroid hormones in pregnant women with uterine myoma. Meditsinskiy sovet = Medical Council. 2020;(3):160-163. (In Russ.) https://doi.org/10.21518/2079-701X-2020-3-160-163